Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Smith KungwankiattichaiWeerapat OwattanapanichThanawat RattanathammetheeEkarat RattarittamrongChantiya ChanswangphuwanaChantana PolprasertWasithep LimvorapitakSupawee SaengboonPimjai NiparuckTeeraya PuavilaiJakrawadee JulamaneePirun SaelueChinadol WanitpongpunKannadit PrayongratanaChantarapa SriswasdiChajchawan NakhakesPublished in: Hematology (Amsterdam, Netherlands) (2023)
APL; acute promyelocytic leukemia; ATRA; all-transretinoic acid; CR; complete remission; DS; differentiation syndrome; ECOG; Eastern Cooperative Oncology Group; ED; early death; HR; hazard ratio; IQR; interquartile range; LFS; leukemia-free survival; OS; overall survival; WBC; white blood cell.